<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>229-FINGOLIMOD.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="FINGOLIMOD" rxcui="1012892">
<ATC code="L04AA27" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="BRADYCARDIA INDUCING DRUGS" code="C0N0S0" /></DRUG2>
<DESCRIPTION>Increase of the bradycardia inducing effects which can have fatal consequences. The beta-blocking agents are even more at risk since they inhibit the adrenergic compensation mechanisms</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
<COMMENT>Clinical monitoring and continuous EKG during the 24 hours following the first dose.</COMMENT>
</INTERACTION>
</INTERACTIONS>
